Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
(deep dive), GLP-1 Receptor Agonist
Almost no insurance covers compounded peptide therapy, so these are cash-pay figures
Due to metabolism by the microbiota of its residual portion (upon intestinal absorption) and the formation of indolic derivatives that effectively activate anti-inflammatory receptors (AhRs)
According to the FDA label, the molecule is built from two identical, disulfide-linked chains, each one carrying a GLP-1 analog sequence covalently attached by a small peptide linker to the Fc portion of a modified human immunoglobulin G4 antibody
Incredible Beta Test Results: 28 People, 550 Pounds Lost
US$ 24.57
US$ 25.68
US$ 26.43
